On 23rd September 2026, Switzerland’s upper house of parliament, the Council of States, voted to require the Swiss parent bank of UBS Group AG [SWX: UBSG] to back the value of its foreign subsidiaries with 90% Common Equity Tier 1 (CET1) capital, a decision UBS says would require ~$16bn of additional capital.
Download PDF Introduction Switzerland has long been a symbol of financial stability as a nation whose conservative banking culture, strong currency, and independent central bank made it a safe haven in times of global stress. Yet beneath this reputation lies a paradox. The very institutions meant to anchor stability now Read more…
Download PDF Introduction The Fed’s buying spree and general pandemic response has recently scooped up most of the media attention around central banking operations. The world of financial markets stands in awe when Jerome Powell speaks of or hints at the Fed’s next moves. However, the Swiss National Bank likes Read more…
Liberty Global plc [LBTYA: NASDAQ] – Market cap as of March 10th $18.36bn Sunrise Communications Group AG [SRCG: SW] – Market cap as of March 10th CHF3.41bn ($3.41bn) Introduction On February 27, 2019, Liberty Global, the biggest international TV and broadband internet company, agreed to the sale of its Swiss Read more…
Temenos Group (SWX:TEMN) – market cap as of 23/02/2018: CHF7.60bn Fidessa Group (LON:FDSA) – market cap as of 23/02/2018: GBP1.47bn Introduction On February 21st, 2018, the boards of both Temenos and Fidessa have reached an agreement for the takeover of the former over the latter for £1.4 billion. The two Read more…
Clariant AG (VTX: CLN) – market cap as of 23/09/2017: CHF7.74bn Hunstman Corporation (NYSE: HUN) – market cap as of 23/09/2017: $6.55bn Introduction Clariant and Huntsman unveiled plans to create a global specialty chemical company in May, saying they expected the transaction to close by the end of 2017. The Read more…
Johnson & Johnson (NYSE: JNJ) — market cap as of 10/02/2017: $310.36bn Actelion (VTX: ATLN) – market cap as of 10/02/2017: CHF 28.13bn Introduction On the January 26, 2017, the US healthcare behemoth Johnson & Johnson announced the acquisition of the Swiss biotech company Actelion for $30bn in cash. Read more…